These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1084448)

  • 1. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
    Altman R; Boullon F; Rouvier J; Raca R; de la Fuente L; Favaloro R
    J Thorac Cardiovasc Surg; 1976 Jul; 72(1):127-9. PubMed ID: 1084448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves.
    Altman R; Rouvier J; Gurfinkel E; D'Ortencio O; Manzanel R; de La Fuente L; Favaloro RG
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):427-31. PubMed ID: 1999935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
    Hartz RS; LoCicero J; Kucich V; DeBoer A; O'Mara S; Meyers SN; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Oct; 92(4):684-90. PubMed ID: 3762199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
    Hill JD; LaFollette L; Szarnicki RJ; Avery GJ; Wilson RM; Gerbode F; Kerth WJ; Rodvien R
    J Thorac Cardiovasc Surg; 1982 May; 83(5):718-23. PubMed ID: 6978975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
    Pengo V; Peruzzi P; Marzari A; Zanon F; Banzato A; Schivazappa L
    G Ital Cardiol; 1989 Dec; 19(12):1125-8. PubMed ID: 2561357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin anticoagulation in children with mechanical aortic valves.
    Verrier ED; Tranbaugh RF; Soifer SJ; Yee ES; Turley K; Ebert PA
    J Thorac Cardiovasc Surg; 1986 Dec; 92(6):1013-20. PubMed ID: 3784585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years.
    Moggio RA; Hammond GL; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1978 Feb; 75(2):296-9. PubMed ID: 625136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thromboembolic and hemorrhagic complications in valve prosthesis patients].
    Ben Ismail M; Abid F; Abid A; M'Zah N; Chaouche H; Kedidi N
    Ann Cardiol Angeiol (Paris); 1983 Jun; 32(4):237-45. PubMed ID: 6614815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.